Gelsevirine (Gelsemium Alkaloid · Respiratory Toxin · Pharmacological Reference)

Compound	Gelsevirine (Gelsemium sempervirens major toxic alkaloid)
Class	Alkaloid — Indole (Gelsemium-type MIA)
CAS	1354-84-3
Molecular formula	C₂₀H₂₂N₂O₃
Primary sources	Gelsemium sempervirens (yellow jessamine/Carolina jasmine), Gelsemium elegans
Plant part	Roots, stems, leaves, flowers
Claim strength	Emerging (toxicology)
Key applications	Toxicological reference; Gelsemium alkaloid pharmacology; respiratory physiology; informational-only
Buy from Herbuno	Informational reference — see HerbIQ Compound Index →

Name origin: Gelsevirine is named after Gelsemium, the genus name derived from the Italian "gelsomino" (jasmine), reflecting the plant's jasmine-like fragrant flowers. It is one of several indole MIA alkaloids in Gelsemium sempervirens alongside gelsemine (the principal toxic alkaloid), koumine, and gelsemicine. Traditional use: Gelsemium sempervirens (yellow jessamine, Confederate jessamine, false jasmine) is native to the southeastern US and is the state flower of South Carolina. It has a history in American Eclectic medicine for neuralgia, facial pain, and fever — always with careful dosing warnings given the narrow margin between therapeutic and toxic doses. Gelsemium roots contain all principal alkaloids including gelsevirine; the plant has no safe traditional oral use outside carefully supervised professional contexts. Research trajectory: Gelsevirine, like other Gelsemium alkaloids, acts on nicotinic acetylcholine receptors (nAChR) and voltage-gated ion channels. Its primary pharmacological significance is toxicological — it contributes to the respiratory depression and neuromuscular paralysis characteristic of Gelsemium poisoning. Research distinguishing gelsevirine's contribution from gelsemine's is limited; the alkaloids act synergistically. Safety context: Gelsemium sempervirens poisoning occurs via ingestion of plant material (particularly roots), honey from Gelsemium nectar (rare), or accidental exposure. Symptoms include diplopia, ptosis, respiratory depression, and cardiovascular collapse. All parts of the plant are toxic; there is no antidote.

---

Pharmacological Profile of Gelsevirine

Nicotinic acetylcholine receptor (nAChR) activity: Gelsevirine acts at multiple nAChR subtypes — inhibiting neuromuscular junction (alpha-1 containing) and autonomic ganglionic (alpha-3) nAChRs, contributing to the skeletal muscle weakness and autonomic dysfunction of Gelsemium poisoning. Voltage-gated sodium channel blocking activity adds to the CNS depressant profile. Claim strength: Moderate (mechanistic).

Respiratory depression: Gelsevirine contributes to the characteristic respiratory depression of Gelsemium poisoning through combined effects on respiratory muscle neuromuscular transmission, central respiratory drive suppression, and possible direct effects on medullary respiratory centres. In animal poisoning studies, respiratory failure is the primary cause of death. Claim strength: Moderate (toxicology).

Relative potency vs. gelsemine: Gelsevirine is considered less acutely toxic than gelsemine per unit weight, but acts synergistically with the full alkaloid complement. The relative contribution of gelsevirine versus gelsemine to Gelsemium poisoning toxicity is not precisely apportioned in clinical toxicology reports, which describe effects of the whole plant alkaloid mixture. Claim strength: Emerging.

Historical analgesic and anti-inflammatory: American Eclectic physicians used Gelsemium preparations for facial neuralgia (trigeminal neuralgia precursor concept) and fever — applications now understood to involve nAChR-mediated nerve block and possible temperature regulatory effects. These historical uses were at doses carefully titrated to avoid diplopia (a recognised early toxicity marker). Claim strength: Emerging (historical).

---

Safety and Research Context

Gelsemium sempervirens poisoning is a documented clinical toxicology entity. Cases include children ingesting flowers or berries, adults ingesting roots, and rare honey intoxication from bees foraging exclusively on Gelsemium. Treatment is supportive — there is no specific antidote; respiratory support is the primary intervention.

EU regulatory status: Gelsemium sempervirens is on restricted botanical lists in several EU member states. The EU Herbal Monograph and Safety Guidance frameworks do not include Gelsemium as a safe traditional herbal medicine for internal use. German Commission E has no positive monograph for Gelsemium.

No supplement or nutraceutical application for gelsevirine or any Gelsemium alkaloid is appropriate. The HerbIQ index documents gelsevirine alongside koumine to complete the Gelsemium alkaloid pharmacological reference series.

Formulators encountering Gelsemium in raw material supply chains should treat any Gelsemium-containing botanical raw material with extreme caution. Cross-contamination of other botanical collections with Gelsemium has caused poisoning incidents; botanical identification verification is essential.

---

Frequently Asked Questions — Gelsevirine

What are the symptoms of Gelsemium poisoning?
Early symptoms include diplopia (double vision — a characteristic Gelsemium toxicity marker), ptosis (drooping eyelids), dilated pupils, and muscle weakness, reflecting nicotinic acetylcholine receptor inhibition at the neuromuscular junction. Progression involves hypotension, bradycardia, profound muscle weakness, respiratory depression, and respiratory arrest. CNS effects include drowsiness, convulsions, and coma at severe doses. Onset is typically within 30–60 minutes of oral ingestion.

Can honey from Gelsemium be toxic?
Yes, though rare. Cases of honey intoxication from Gelsemium-foraging bees have been reported — primarily in regions where Gelsemium sempervirens is a dominant springtime nectar source in the southeastern US. The alkaloid content in honey depends on the proportion of Gelsemium nectar in the honey; monofloral Gelsemium honey is the highest risk. Standard commercial honey from diverse botanical sources does not present a meaningful Gelsemium alkaloid risk.

How does gelsevirine differ from gelsemine pharmacologically?
Both are Gelsemium MIA alkaloids acting at nAChR subtypes, but their receptor subtype selectivity and binding kinetics differ. Gelsemine is the more extensively studied and is considered the primary toxic alkaloid of G. sempervirens. Gelsevirine acts synergistically; its independent contribution to toxicity has not been fully characterised in isolation. Structurally, gelsevirine carries an additional oxygen substituent (3-hydroxyl) relative to gelsemine.

Is Gelsemium sempervirens used in homeopathy and is that safe?
Yes — Gelsemium 30C and 200C are among the most widely used homeopathic preparations, prescribed for influenza-type illness, anxiety, and neuralgia. At homeopathic dilutions (10⁻⁶⁰ concentration for 30C), no alkaloid molecules remain; the preparations are pharmacologically inert regarding Gelsemium alkaloids and present no toxicological risk from the alkaloid content. The clinical efficacy of homeopathic Gelsemium is a separate question governed by the overall evidence base for homeopathy.

Related compounds: Koumine, Strychnine, Brucine, Lappaconitine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery